肝癌患者肝动脉化疗栓塞术后恶心和呕吐的危险因素及评估工具研究进展
Research progress in risk factors and evaluation tools for nausea and vomiting after hepatic artery chemoembolization in liver cancer patients
梁轶 1严忠婷 1桑玉还 1杨波 2王芳 1袁媛 1鞠梅1
作者信息
- 1. 646000 四川泸州 西南医科大学护理学院
- 2. 西南医科大学附属医院介入医学部
- 折叠
摘要
原发性肝癌是我国常见恶性肿瘤,在肿瘤致死病因中居于第二位,严重威胁国民的生命健康.肝动脉化疗栓塞(TACE)是无法通过手术根治的肝癌患者的首选治疗方法,对于延长患者生命具有重要意义.但TACE术后的高恶心呕吐发生率,是导致患者治疗依从性下降的重要原因,严重影响患者的生活质量和介入治疗的效果.本文对国内外TACE术后患者恶心和呕吐的特点、危险因素、评估工具进行了综述,以期对TACE术后恶心和呕吐进行早期识别及有效的干预提供依据.
Abstract
Primary liver cancer(PLC)is a common malignant tumor in China.It ranks second in the cause of tumor mortality and it is a serious threat to the lives and health of people.Transcatheter arterial chemoembolization(TACE)is the preferred treatment for patients with HCC who cannot be surgically cured,which is of great significance for prolonging the patient's life.However,the incidence of nausea and vomiting after TACE is very high,which is an important reason for the decline of patient treatment compliance,which seriously affects the quality of life and the effect of interventional therapy.This paper reviews the domestic and abroad literature concerning the nausea and vomiting in patients after TACE,focusing on the clinical features of nausea and vomiting,the risk factors and the assessment tools,so as to provide a scientific basis for clinical early identification and effective intervention of nausea and vomiting after TACE.(J Intervent Radiol,2024,33:565-570)
关键词
肝癌/肝动脉化疗栓塞术/恶心/呕吐/危险因素Key words
liver cancer/transcatheter arterial chemoembolization/nausea/vomiting/risk factor引用本文复制引用
基金项目
自贡市哲学社会科学重点研究基地健康人文研究中心项目(JKRWY22-28)
泸州市人民政府-西南医科大学科技战略合作项目(2020LZXNYDJ12)
西南医科大学校级科研项基金(2023QN109)
出版年
2024
NETL
NSTL
万方数据